factors, and multiple logistic regression accounted for interactions and confounders.
MICROBIAL SELECTION PRESSURE AND THE RISK OF SUBSEQUENT GRAM-NEGATIVE EARLY ONSET SEPSIS IN WOMEN TREATED WITH ERYTHROMYCIN FOLLOWING PRETERM PROLONGED RUPTURE OF MEMBRANES
Background: Clinical guidelines recommend a 10-day course of prophylactic erythromycin following preterm prolonged rupture of membranes (PPROM). However, this may result in microbial selection pressure favouring gram-negative colonisation and subsequent increased rate of gram-negative early onset sepsis. We aimed to investigate the impact of prophylactic erythromycin for PPROM on high vaginal and placental bacterial colonization.
Methods: Women who presented with PPROM <30 weeks' completed gestational weeks between January 2012 and December 2015 where identified retrospectively from the perinatal database of Clinical Information Services at the Women's and Children's and linked with the corresponding neonatal data for the relevant pregnancy.
Results: 126 women met inclusion criteria with 79 (63%) treated with erythromycin for a median duration of x days. A high vaginal swab was positive for a Gram-negative organism in 49 (39%) with E Coli identified in 36 (73%). A Gram-negative organism was detected on 16 (12.6%) of placental swabs with E Coli identified in 10 (62%). Of these 70% were multi-drug resistant and all cases had been exposed to prophylactic erythromycin. The proportion of women with placental swabs positive for a Gram-negative organism was higher following antenatal erythromycin treatment compared to those not prophylactically treated (P = 0.02).
Conclusion: Meta-analysis of antibiotic use for PPROM does not explore the variability of effect on different gestational age subgroups. While epidemiological trends have shown a decrease in the frequency of Group B Streptococci infection, in very preterm newborns the risk of gram-negative sepsis may be increased and warrants re-evaluation of current antenatal anti-microbial management. ; Arora C 2 ; Silagy M
POSTNATAL MIDDLE CEREBRAL ARTERY DOPPLER IN FETAL GROWTH RESTRICTION

